Current COVID-19 infections in China feature low prevalence level, mild symptoms: experts
The overall COVID-19 infections in China have entered a low prevalence level since mid-May, and the vast majority of COVID-19 patients show mild symptoms, medical experts said.
Read More
Educators rise to meet new COVID challenge
As COVID-19 cases increase in many parts of the country, a number of educational institutions in China are stepping up their virus intervention efforts, The Paper reported.
Vaccine against XBB variant to be available soon
Vaccines against the XBB variant of the COVID-19 are expected to be available soon, according to Zhong Nanshan, a top respiratory disease expert.
Large-scale COVID reemergence 'unlikely'
The risk of a new large-scale COVID-19 outbreak in China in the short term is minimal, despite a recent uptick in new infections, according to health experts.
China's role in pandemic fight hailed
China has stood out and played a significant role in the global fight against the COVID-19 pandemic over the past three years, experts and officials said.
MORE
57 cases of new Omicron subvariant detected in China
China has detected 57 COVID-19 cases caused by the new Omicron subvariant XBB.1.16 as of Saturday, a Chinese Center for Disease Control and Prevention researcher said on Wednesday.
COVID may originate in humans - study
Humans infected by the COVID-19 virus may have introduced the novel coronavirus to susceptible animals at the Huanan seafood market in Wuhan, Hubei province, where the first COVID-19 cases were reported in China, Chinese researchers said on Saturday.
Mainland detects first BQ.1 variant of coronavirus
The Chinese mainland detected its first BQ.1 case — a variant of key concern — this week, according to information released by the Chinese Center for Disease Control and Prevention on Saturday.
Does the COVID-19 vaccine weaken your immune system?
Six fallacies and truths about China's epidemic control
Fact Check: The sooner to get infected, the better?
Fact-check on vaccine-related misinformation
BQ.1 and XBB: What you need to know
China has detected BQ.1 and XBB from imported cases. How virulent are these strains? Will they cause new waves of infections? Here's what Chinese experts are saying.
Explainer: Experts on key COVID-19 concerns through FAQs
In response to questions of public concern regarding China's fight against COVID-19, Xinhua reporters have interviewed experts with the State Council inter-agency task force for COVID-19 response to provide answers.
As COVID wanes, what do people expect from new year?
Expert interprets nation's new COVID-19 treatment protocol
Did China scrap COVID controls overnight?
Guidance on home quarantine for COVID-infected people
How to protect yourself against COVID in various scenarios
Vaccinations remain critical in protecting China's elderly population
Professionals offer valuable advice on how to cope in times of high stress
TCM study identifies compounds in COVID drug
Researchers have successfully identified key antiviral and bioactive anti-inflammatorial compounds in a traditional Chinese medicine therapy widely used to treat COVID-19. The findings are expected to shed light on the way TCM works against the virus, and to help promote global acceptance of TCM.
TCM's role in COVID treatment to be promoted
Health authorities provide list of Chinese medicines for COVID-19
TCM plays key role in virus treatment mix
Technical guideline for the inoculation of COVID-19 vaccines
Report: China's fight against COVID-19 (full text)
White paper - Fighting Covid-19: China in Action
Diagnosis, treatment protocol for COVID (tentative 8th edition)
State Council Information Office
